Supernus Pharmaceuticals (SUPN) stock, explained like you're 5

Is Supernus Pharmaceuticals a small, medium or large cap company?

No. Supernus Pharmaceuticals is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 2.5 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Supernus Pharmaceuticals makes money

• Selling medicines, medical devices or healthcare services.
• Insurance premiums or hospital and clinic fees.
• Research and licensing deals.

What moves SUPN stock

• Results from clinical trials and approvals from regulators.
• Drug prices, insurance rules and government policy.
• Patents running out and new competing treatments.

In the news lately

• Supernus Pharmaceuticals, Inc. (SUPN) Stock Price, News, Quote & History (Yahoo! Finance Canada)
• Supernus Pharmaceuticals stock hits 52 week low at 40.5 USD (Investing.com)
• Supernus Pharmaceuticals: The Merger Is Priced Like A Retreat, But Reads Like A Reverse Takeover (Seeking Alpha)
• Is Supernus Pharmaceuticals (SUPN) Still Worth A Look After Its Valuation Reset? (Simply Wall Street)
• Why Supernus Pharmaceuticals Stock Topped the Market Today (The Motley Fool)

Key terms to know before you follow SUPN

• Market cap
• P/E ratio
• EPS (earnings per share)
• Earnings report
• Volatility